Patients Views & Analysis

Views & Analysis

Patients

pharmaphorum podcast Episode, 260 - Ramy Younes, Boehringer Ingelheim

The cardio-renal-metabolic space and obesity as a chronic di...

The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

Patients

A hand grabs and breaks a DNA chain to represent biohacking

Why biohackers are ditching vague health metrics

Precision diagnostics enable targeted therapeutics.

Patients

Hands in a circle point to the middle where EU stars are, blue background

Stronger together: The future of psychiatry in a changing Eu...

Mental disorders account for a significant share of economic cost across EU Member States and the United Kingdom.

Patients

More than a discount: How intelligent copay programmes are r...

Brian Laird explains a more dynamic, data-driven approach to copay is redefining affordability, creating a new standard for balancing patient support.

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

The cardio-renal-metabolic space and obesity as a chronic di...

Why biohackers are ditching vague health metrics

Stronger together: The future of psychiatry in a changing Eu...

More than a discount: How intelligent copay programmes are r...

Providing patient access to new therapies, with Dean Erhardt

From access to advocacy: Turning patients into brand champio...

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks